The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer's disease.

Frontiers in molecular neuroscience(2023)

引用 0|浏览14
暂无评分
摘要
Thus, we propose that a reduced ADAM17 expression in cerebral microvessels impairs vasodilator function, which may contribute to the development of cognitive dysfunction in APP/PS1 mice, and that ADAM17 can potentially be targeted for therapeutic intervention in AD.
更多
查看译文
关键词
Alzheimer’s disease,a disintegrin and metalloproteinase 17,cognitive decline,mouse model,vasodilation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要